Carlo Selmi

Author PubWeight™ 126.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet 2008 6.42
2 European population substructure: clustering of northern and southern populations. PLoS Genet 2006 5.27
3 Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010 3.15
4 Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005 2.15
5 Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004 2.13
6 Presence of fetal DNA in maternal plasma decades after pregnancy. Hum Genet 2002 2.05
7 Probiotics and immunity. J Gastroenterol 2009 1.79
8 Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol 2004 1.57
9 Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009 1.55
10 The SAPHO syndrome. Semin Arthritis Rheum 2012 1.50
11 Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev 2005 1.48
12 Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2011 1.48
13 The epigenetics of autoimmunity. Cell Mol Immunol 2011 1.47
14 X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005 1.41
15 A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis. J Med Food 2014 1.41
16 Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008 1.40
17 Apocalypsal versus apocryphal: the role of retroviruses in primary biliary cirrhosis. Am J Gastroenterol 2004 1.39
18 Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability. Clin Neurophysiol 2010 1.39
19 The retroviral myth of primary biliary cirrhosis: is this (finally) the end of the story? J Hepatol 2009 1.39
20 Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 2005 1.37
21 Is autoimmunity a matter of sex? Autoimmun Rev 2008 1.35
22 The autoimmune bases of infertility and pregnancy loss. J Autoimmun 2012 1.27
23 Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 2007 1.25
24 The consequences of apoptosis in autoimmunity. J Autoimmun 2008 1.24
25 Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009 1.24
26 A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007 1.23
27 From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2005 1.22
28 Juvenile idiopathic arthritis. Autoimmun Rev 2005 1.18
29 Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006 1.15
30 Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J Autoimmun 2005 1.14
31 Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 2007 1.12
32 Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 2005 1.10
33 Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007 1.10
34 Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 2008 1.08
35 Update on primary biliary cirrhosis. Dig Liver Dis 2010 1.08
36 Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. Ann Surg Oncol 2009 1.08
37 Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology 2009 1.08
38 The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010 1.07
39 The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008 1.05
40 Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010 1.04
41 Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology 2008 1.03
42 Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. J Hepatol 2010 1.02
43 Currents concepts on the immunopathology of amyloidosis. Clin Rev Allergy Immunol 2010 1.02
44 Monosodium glutamate (MSG) intake is associated with the prevalence of metabolic syndrome in a rural Thai population. Nutr Metab (Lond) 2012 1.02
45 Avian models with spontaneous autoimmune diseases. Adv Immunol 2006 0.98
46 A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2009 0.98
47 The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun 2012 0.98
48 Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug. J Neurol Neurosurg Psychiatry 2012 0.96
49 Criteria for environmentally associated autoimmune diseases. J Autoimmun 2012 0.95
50 X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci 2007 0.95
51 Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun 2009 0.94
52 Natural autoantibodies in the physiology and pathophysiology of the immune system. J Autoimmun 2013 0.94
53 The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. J Autoimmun 2013 0.94
54 Liver abnormalities in connective tissue diseases. Best Pract Res Clin Gastroenterol 2013 0.94
55 Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 2007 0.93
56 Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 2012 0.92
57 Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver. Exp Biol Med (Maywood) 2008 0.91
58 Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 2008 0.90
59 Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 2011 0.90
60 The therapeutic potential of epigenetics in autoimmune diseases. Clin Rev Allergy Immunol 2012 0.90
61 SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis. Clin Dev Immunol 2005 0.89
62 Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome. Dig Liver Dis 2012 0.89
63 The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol 2011 0.88
64 Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 2005 0.88
65 Geographic clusters of primary biliary cirrhosis. Clin Dev Immunol 2004 0.88
66 Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations. Liver Transpl 2010 0.87
67 Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis. Clin Exp Rheumatol 2014 0.86
68 Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease. Immunol Res 2015 0.86
69 Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. Autoimmun Rev 2010 0.85
70 Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis. Ann N Y Acad Sci 2009 0.85
71 Clinical features and management of primary biliary cirrhosis. World J Gastroenterol 2008 0.85
72 Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis. Autoimmunity 2008 0.85
73 Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Clin Rev Allergy Immunol 2012 0.84
74 Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007 0.84
75 Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun 2012 0.84
76 Genetic polymorphisms of transforming growth factor beta-1 promoter and primary biliary cirrhosis in Japanese patients. Ann N Y Acad Sci 2007 0.83
77 Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. Clin Rev Allergy Immunol 2010 0.83
78 Dairy proteins and the response to pneumovax in senior citizens: a randomized, double-blind, placebo-controlled pilot study. Ann N Y Acad Sci 2010 0.83
79 Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 2005 0.83
80 The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease. Ann N Y Acad Sci 2010 0.83
81 Interleukin-1 Inhibition in Behçet's disease. Isr Med Assoc J 2016 0.83
82 Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study. Medicine (Baltimore) 2015 0.83
83 Fractalkine and other chemokines in primary biliary cirrhosis. Int J Hepatol 2011 0.82
84 Autoimmune features in metabolic liver disease: a single-center experience and review of the literature. Clin Rev Allergy Immunol 2013 0.82
85 The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol 2015 0.81
86 Viruses and autoantibodies in biliary atresia. Gastroenterology 2010 0.81
87 Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis. Hepatol Res 2008 0.81
88 Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology 2005 0.81
89 Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis. Hepatology 2005 0.81
90 Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol 2009 0.81
91 Lack of PBC-specific antimitochondrial antibodies in patients with Chlamydia pneumoniae infection. J Gastroenterol Hepatol 2005 0.80
92 The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis. Ann N Y Acad Sci 2007 0.80
93 The autoimmune side of heart and lung diseases. Clin Rev Allergy Immunol 2013 0.79
94 Methotrexate for primary biliary cirrhosis: who is to be trusted? Dig Dis Sci 2010 0.79
95 Primary biliary cirrhosis: solving the enigma. Ann N Y Acad Sci 2005 0.79
96 Efficacy of medical therapy in a case of idiopathic pulmonary fibrosis due to gastroesophageal reflux disease. Intern Emerg Med 2009 0.78
97 Serum autoantibodies: a road map for the clinical hepatologist. Autoimmunity 2008 0.78
98 Monosodium glutamate (MSG) consumption is associated with urolithiasis and urinary tract obstruction in rats. PLoS One 2013 0.78
99 Cutting-edge issues in primary biliary cirrhosis. Clin Rev Allergy Immunol 2012 0.77
100 Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol 2009 0.77
101 The autoinflammatory side of systemic sclerosis. Isr Med Assoc J 2015 0.77
102 Autoimmunity and cancer. Asian Pac J Cancer Prev 2012 0.77
103 Serum autoantibodies for the diagnosis and management of autoimmune liver diseases. Expert Rev Gastroenterol Hepatol 2012 0.77
104 Primary biliary cirrhosis with multinucleated hepatocellular giant cells: implications for pathogenesis of primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2006 0.77
105 Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis. Clin Rev Allergy Immunol 2005 0.76
106 Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity? Ann N Y Acad Sci 2005 0.76
107 Thyroid dysfunction in women with systemic sclerosis. Ann N Y Acad Sci 2007 0.76
108 Autoantibody IgG subclasses to recombinant antigens and the role of bacterial stimuli in primary biliary cirrhosis. Hepatol Res 2009 0.76
109 Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting. BMC Med 2014 0.75
110 The bile duct cell: a bully or a victim? Liver Transpl 2005 0.75
111 Tumor Necrosis Factor-Alpha at the Crossroad between Rheumatoid Arthritis and Autoimmune Cholangitis. Isr Med Assoc J 2015 0.75
112 Response to Dr. Roger's letter: further studies are necessary in order to conclude a causal association between the consumption of monosodium L-glutamate (MSG) and the prevalence of metabolic syndrome in the rural Thai population. Nutr Metab (Lond) 2013 0.75
113 Common variants of the matrix metalloproteinase-3 (stromelysin) gene promoter in primary biliary cirrhosis. Gastroenterology 2002 0.75
114 Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease. Medicine (Baltimore) 2016 0.75
115 Late-onset autoimmunity: the paradigm of primary biliary cirrhosis--a mini-review. Gerontology 2008 0.75
116 Orthostatic intolerance and coronary reserve: a matter of a certain gravity. Intern Emerg Med 2010 0.75
117 Soluble CD40L in plasma of patients with primary biliary cirrhosis. Ann N Y Acad Sci 2005 0.75
118 Serum islet cell autoantibodies during interferon alpha treatment in patients with HCV-genotype 4 chronic hepatitis. Clin Dev Immunol 2006 0.75
119 The protean ocular involvement in monogenic autoinflammatory diseases: state of the art. Clin Rheumatol 2015 0.75
120 Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Clin Dev Immunol 2006 0.75
121 Vaccines in the 21st century: the genetic response and the innocent bystander. Autoimmun Rev 2005 0.75
122 Are Helminths to be Trusted as Allies in the War against Autoimmunity and Chronic Inflammation? Isr Med Assoc J 2016 0.75
123 The challenge of treating orphan disease. Clin Rev Allergy Immunol 2014 0.75
124 Sex Differences in the Treatment of Psoriatic Arthritis: A Systematic Literature Review. Isr Med Assoc J 2016 0.75